Skip directly to content


The worldwide effort to control tuberculosis (TB) is failing. The ongoing spread of TB, including drug-resistant strains, presents a grave threat, especially to HIV-positive people in countries with high rates of both diseases.

HIV infection makes a person much more susceptible to TB disease, and it fuels the increase in TB cases, especially in sub-Saharan Africa. Furthermore, the spread of TB that is drug-resistant demonstrates the failure of established strategies for TB control. Due to the inadequacy of current TB diagnostic tools and treatments, as well as poor coordination of TB and HIV services, TB is the leading cause of death for HIV-positive people globally.

The Treatment Action Group’s TB/HIV Project works to strengthen global and U.S.-focused advocacy to increase funding and ensure ambitious and improved research, programs, and policy to ensure universal access to quality services for people with TB and HIV. The project works to:

  • Catalyze global leadership to accelerate momentum toward universal access for high-quality TBand TB/HIVservices including implementation of the revised WHO policy on collaborative TB/HIV activities; and
  • Accelerate funding and progress in R&D for better tools to prevent, diagnose, and treat TB (including TB among people living with HIV).